C44H49F3N10O4 — CID 170432930
3-[7-[4-[[4-[4-[(2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl)amino]-5-fluoro-2-pyridinyl]piperazin-1-yl]methyl]piperidin-1-yl]-1-methylindazol-3-yl]piperidine-2,6-dione (PubChem CID 170432930) has the molecular formula C44H49F3N10O4 and a molecular weight of 838.94 g/mol. Its IUPAC name is 3-[7-[4-[[4-[4-[(2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl)amino]-5-fluoro-2-pyridinyl]piperazin-1-yl]methyl]piperidin-1-yl]-1-methylindazol-3-yl]piperidine-2,6-dione.
| Compound Name | 3-[7-[4-[[4-[4-[(2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl)amino]-5-fluoro-2-pyridinyl]piperazin-1-yl]methyl]piperidin-1-yl]-1-methylindazol-3-yl]piperidine-2,6-dione |
|---|---|
| PubChem CID | 170432930 |
| Molecular Formula | C44H49F3N10O4 |
| Molecular Weight | 838.94 g/mol |
| Exact Mass | 838.39 |
| IUPAC Name | 3-[7-[4-[[4-[4-[(2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl)amino]-5-fluoro-2-pyridinyl]piperazin-1-yl]methyl]piperidin-1-yl]-1-methylindazol-3-yl]piperidine-2,6-dione |
| SMILES | Cn1nc(C2CCC(=O)NC2=O)c2cccc(N3CCC(CN4CCN(c5cc(Nc6ccc7c(c6)c6c(c(=O)n7C)OCC(F)(F)C(C7CC7)N6)c(F)cn5)CC4)CC3)c21 |
| InChI | InChI=1S/C44H49F3N10O4/c1-53-33-10-8-27(20-30(33)38-40(43(53)60)61-24-44(46,47)41(51-38)26-6-7-26)49-32-21-35(48-22-31(32)45)57-18-16-55(17-19-57)23-25-12-14-56(15-13-25)34-5-3-4-28-37(52-54(2)39(28)34)29-9-11-36(58)50-42(29)59/h3-5,8,10,20-22,25-26,29,41,51H,6-7,9,11-19,23-24H2,1-2H3,(H,48,49)(H,50,58,59) |
| InChIKey | OTAKZBRUERGCFM-UHFFFAOYSA-N |
| XLogP | 5.48 |
| TPSA | 141.89 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 61 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 838.94 |
| LogP ≤ 5 | 5.48 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|